Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2013 2
2014 2
2015 4
2016 3
2017 5
2018 6
2019 4
2020 4
2021 14
2022 14
2023 15
2024 7
2025 6
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.
Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, Martín-Quirós A, Caraco Y, Williams-Diaz A, Brown ML, Du J, Pedley A, Assaid C, Strizki J, Grobler JA, Shamsuddin HH, Tipping R, Wan H, Paschke A, Butterton JR, Johnson MG, De Anda C; MOVe-OUT Study Group. Jayk Bernal A, et al. N Engl J Med. 2022 Feb 10;386(6):509-520. doi: 10.1056/NEJMoa2116044. Epub 2021 Dec 16. N Engl J Med. 2022. PMID: 34914868 Free PMC article. Clinical Trial.
Influenza Vaccine Immunogenicity in Hemodialysis Patients.
Shurygina AP, Romanovskaya-Romanko E, Krivitskaya V, Sergeeva M, Buzitskaya J, Vasilyev K, Shuklina M, Vishnevskii K, Dmitry S, Aleksey T, Lioznov D, Stukova M. Shurygina AP, et al. Among authors: lioznov d. Vaccines (Basel). 2026 Jan 4;14(1):63. doi: 10.3390/vaccines14010063. Vaccines (Basel). 2026. PMID: 41600979 Free PMC article.
SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19.
Stanevich OV, Alekseeva EI, Sergeeva M, Fadeev AV, Komissarova KS, Ivanova AA, Simakova TS, Vasilyev KA, Shurygina AP, Stukova MA, Safina KR, Nabieva ER, Garushyants SK, Klink GV, Bakin EA, Zabutova JV, Kholodnaia AN, Lukina OV, Skorokhod IA, Ryabchikova VV, Medvedeva NV, Lioznov DA, Danilenko DM, Chudakov DM, Komissarov AB, Bazykin GA. Stanevich OV, et al. Among authors: lioznov da. Nat Commun. 2023 Jan 10;14(1):149. doi: 10.1038/s41467-022-34033-x. Nat Commun. 2023. PMID: 36627290 Free PMC article.
A highly divergent sample from a nearly extinct SARS-CoV-2 lineage in a patient with long-term COVID-19.
Nabieva E, Klink GV, Komissarov AB, Zaitsev SV, Sergeeva M, Fadeev AV, Komissarova K, Ivanova A, Pisareva M, Kudrya K, Danilenko D, Lioznov D, Hisner R, Gueli F, Peacock TP, Roemer C, Bazykin GA. Nabieva E, et al. Among authors: lioznov d. Front Cell Infect Microbiol. 2025 Sep 19;15:1623390. doi: 10.3389/fcimb.2025.1623390. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 41050757 Free PMC article.
Spread of endemic SARS-CoV-2 lineages in Russia before April 2021.
Klink GV, Safina KR, Garushyants SK, Moldovan M, Nabieva E, Komissarov AB, Lioznov D, Bazykin GA; CoRGI (Coronavirus Russian Genetic Initiative) Consortium. Klink GV, et al. Among authors: lioznov d. PLoS One. 2022 Jul 20;17(7):e0270717. doi: 10.1371/journal.pone.0270717. eCollection 2022. PLoS One. 2022. PMID: 35857745 Free PMC article.
An Early SARS-CoV-2 Omicron Outbreak in a Dormitory in Saint Petersburg, Russia.
Klink GV, Danilenko D, Komissarov AB, Yolshin N, Shneider O, Shcherbak S, Nabieva E, Shvyrev N, Konovalova N, Zheltukhina A, Fadeev A, Komissarova K, Ksenafontov A, Musaeva T, Eder V, Pisareva M, Nekrasov P, Shchur V, Bazykin GA, Lioznov D. Klink GV, et al. Among authors: lioznov d. Viruses. 2023 Jun 22;15(7):1415. doi: 10.3390/v15071415. Viruses. 2023. PMID: 37515103 Free PMC article.
Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia.
Lioznov D, Amosova I, Sheetikov SA, Zornikova KV, Serdyuk Y, Efimov GA, Tsyferov M, Khmelevskii M, Afanasiev A, Khomyakova N, Zubkov D, Tikhonov A, Zhu T, Barreto L, Dzutseva V. Lioznov D, et al. PLoS One. 2023 Mar 8;18(3):e0278878. doi: 10.1371/journal.pone.0278878. eCollection 2023. PLoS One. 2023. PMID: 36888640 Free PMC article. Clinical Trial.
87 results